Clinical Effect of Phenytoin Mucoadhesive Paste on Wound Healing After Oral Biopsy
NCT ID: NCT01680042
Last Updated: 2012-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
40 participants
INTERVENTIONAL
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phenytoin in the Healing of Clean Surgical Wounds
NCT02413658
Safety Study of Topical Human FGF-1 for Wound Healing
NCT00916292
FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers
NCT00425178
Efficacy of Phenytoin Phonophoresis on Pressure Ulcer Healing
NCT05542589
Topical Mebo Versus Lidocane in Healing Time of Traumatic Oral Ulcer
NCT06184282
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
phenytoin paste
this group receives phenytoin paste after oral biopsy
Phenytoin paste
usual mucoadhesive paste
this group receives the usual mucoadhesive paste without phenytoin after oral biopsy
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phenytoin paste
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shahid Beheshti University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
somayeh alirezaei
resident
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shaheed Beheshti University
Tehran, , Iran
Shahid Beheshti Medical University
Tehran, , Iran
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Merck-023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.